Other Headlines

A DOTmed Business News exclusive report.
The LipiScan IVUS combines near-infrared spectroscopy and intravascular ultrasound technologies into one system.
AAMI honors BMET.
Company establishes matching relief fund for Pakistan through Henry Schein Cares Foundation.
Commercial first aid supplier acquires Seattle-based Synergy Logistics' van service and increases customer base.

Have News for Us?

Submit your news on the industry, people, or companies.

Spread The News

Log in or Register to rate this News Story
Be the first to rate this story!

 

More Industry Headlines

Canon to debut first full medical system modality at RSNA DOTmed News got a first look at Canon's new mobile C-Arm at the Canon EXPO 2010 show.

As reactors age, European medical isotope makers look to protect supply chain New partnership will shore up moly availability once a new French reactor goes online in 2015.

Federal: Minnesota Health Care Provider Group Settles FTC Price Fixing Charges A medico-legal entry from DOTmed Business News.

Mass. may be losing millions to superfluous advanced imaging tests The state's Medicaid reimbursement guidelines and loose safeguards against self-referral practices are at fault, according to a new report.

Today's top news stories DOTmed News' Olga Deshchenko summarizes today's top news headlines.

THE HEAVY BURDEN: Are facilities ready for the bariatric population? A DOTmed Business News exclusive.

National Labs fights cancer with medical isotopes One of the nation's labs can now make promising medical isotopes readily available and affordable to researchers.

FDA addresses industry concerns about device-approval process Tuesday's Webcast opened the floor to the industry to express concerns.

European Commission report questions safety of reprocessed single-use devices Report questions the safety and savings of reprocessed single-use devices in Europe, but U.S. reprocessors say it doesn't apply to the American industry.

DOTmed AHRA video: Toshiba America DOTmed News met with Toshiba America at AHRA last week to learn more about the third year of the Putting Patients First grant program.

New drug delivery system
may transform eye cancer treatment

Experimental Silicone Cup: Breakthrough for Eye Disease Patients

by Lynn Shapiro, Writer
A new drug delivery system that uses a tiny silicone cup sealed to the outer surface of the eyeball may greatly improve the way doctors deliver medicine to people with eye diseases, says A. Linn Murphree, M.D., director of the Retinoblastoma Program in The Vision Center at Childrens Hospital, Los Angeles.

Dr. Murphree tells DOTmed News that the tiny cup isolates the medication targeted to the eye from being absorbed into the blood stream. This new delivery system is a safe and non-invasive way of delivering effective doses of medications to the interior of the eye over long periods of time, he says.

Story Continues Below Advertisement
DOTmed Text Ad

Oi Service The 'Cool' Choice- MRI Support - 877-434-4304

Oxford Instruments has been the magnet service company of choice for over 40 years. Specializing in De-icing, Magnet Quench Recovery, Helium Leaks and Complete Cold Head Compressor Support. Trust the experts.


Dr. Murphree is especially interested in kids who have an eye cancer called retinoblastoma but he says the cup can be used to deliver drugs for any disease, including macular degeneration, glaucoma and diabetes.

Eye Drops Ineffective

Currently, the drops used for retinoblastoma and the injections used for macular degeneration are risky and ineffective, he says.

"When we give injections, it's like taking a whole bucket of water and throwing it at a building. We're splashing medicine on the eye, except most of it is running off. He adds that eye drops are just as ineffective, because while most diseases that affect vision are in the back portion of the eye, eye drops can only reach the front of the eye. "Traditionally, we've always had a real problem getting enough medicine inside the eye. So, now we inject medicine into a vein in the eye, but that requires a lot of drug therapy and a lot of side effects," Dr. Murphree says.

Macular degeneration is a case in point. Macular degeneration medicine must be injected into the eye once a month. Shots in the eye can lead to hemorrhaging, retinal detachment, and infections, he says.

"In the past, there was no way of isolating the drug while it slowly diffused into the eye. But the cup isolates the drug from being carried away by the blood vessels around the eye, using a soft silicone that's sealed to the outside of the eye, Dr. Murphree explains.

He says that the silicone cup is first sealed to the eye and is then injected with liquid medication to treat the disease. The cup releases medicine slowly over days or weeks.

Retinoblastoma: Dr. Murphree's Passion

Dr. Murphree is passionate about helping children beat retinoblastoma. Currently, he says, the only way to treat this disease is to inject chemotherapy medication into an eye vein and hope it reaches the cancer cells in one or perhaps both eyes.

"We are giving 99 percent more chemo than is needed to make sure the medicine gets into the eye, but most of it is going into the bloodstream, causing nausea, reducing kids' white cell count, and depressing their immune systems," he says. "Because the drug delivered via the cup is being administered directly into the eye and not systemically, you're not giving more than you need, and you're getting 30 to 40 times more of the drug delivered to the cancer site than with an injection."

Continue reading Experimental Silicone Cup: Breakthrough for Eye Disease Patients...
  Pages: 1 - 2 >>

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2010 DOTmed.com, Inc.
ALL RIGHTS RESERVED